Saturday, 17 October 2026European Markets

VOPAK Stock Was Up By 11.16% Today

Loading stream...

(VIANEWS) - The Market ended the session with VOPAK (VPK.AS) rising 11.16% to €32.88 on Wednesday while AEX-Index jumped 0.12% to €843.67.

About VOPAK

Koninklijke Vopak N.V., an independent tank storage company, stores and handles liquid chemicals, gases, and oil products worldwide. The company owns and operates terminals, including storage tanks, jetties, truck and rail loading stations and pipelines, as well as provide access to road, rail, and pipeline networks. It operates 78 terminals in 23 countries with a storage capacity of 36.6 million cbm. The company was founded in 1616 and is headquartered in Rotterdam, the Netherlands.

Earnings Per Share

As for profitability, VOPAK has a trailing twelve months EPS of €3.13.

PE Ratio

VOPAK has a trailing twelve months price to earnings ratio of 10.5. Meaning, the purchaser of the share is investing €10.5 for every euro of annual earnings.

Volatility

VOPAK's last week, last month's, and last quarter's current intraday variation average was a positive 0.80%, a negative 0.12%, and a positive 0.85%.

VOPAK's highest amplitude of average volatility was 1.03% (last week), 1.01% (last month), and 0.85% (last quarter).

More news about VOPAK (VPK.AS).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com